Scientific Importance/Achievement Grants

Sleep Research Society Young Investigator Award

The deadline to submit nominations for all SRS Awards is Friday, September 17, 2010.

Nominations may be sent via e-mail to ncekosh@srsnet.org or they can be mailed to the Sleep Research Society, Attn: Nick Cekosh, 2510 North Frontage Road, Darien, IL 60561.

This award recognizes an outstanding research effort by a new investigator in the field of sleep research. The basis for evaluation of candidates is a single publication in a refereed journal. The candidate should be the first author; and the article must be published or officially accepted for publication by the application deadline. On the application deadline, the candidate must be within 7 years of obtaining a terminal degree. Exceptions to this criterion will be considered for those applicants who feel that extenuating circumstances warrant such consideration. A letter detailing these considerations must be included with the application.

The award consists of a plaque and a travel honorarium to be applied toward travel to the SLEEP 2011, 25th Annual Meeting of the Associated Professional Sleep Societies. The plaque will be presented at a ceremony at the APSS Annual Meeting.

To apply, candidates must submit, as a single PDF or Word Document, a single CV, documentation of the date of receipt of terminal degree and, if applicable, a letter outlining extenuating circumstances . If a paper is in press at the time of application, a copy of the written notification of the paper’s acceptance for publication must also be included. Applicants should provide the name of a senior investigator who will provide a letter of recommendation. The senior investigator does not need to be an author on the paper or abstract, but should be familiar with the candidate’s role on the research project. The candidate is responsible for ensuring that the letter of recommendation from the senior investigator arrives by the application deadline. In addition, a candidate must be a member in good standing of the SRS or must include a completed application for membership and fee with the award application. Repeat applications from unsuccessful applicants from previous years are encouraged. The Young Investigator Award can only be received once by an individual.

Candidates are welcome to apply for both the Young Investigator Award and the Trainee Travel Fellowship, but in the event the candidate receives the Young Investigator Award, she/he will receive only this award. Multiple awards may be recognized, dependent on the quality of the applications.

International Association for Dental Research Basil Bibby Young Investigator Award

Supported by Unilever

Purpose: The Cariology Group of IADR has established the above Award for the purpose of promoting the interest of young scientists and students in dental caries research and related matters, and to acknowledge excellence of the research conducted by young investigators. The Award is in honor of the founding President of the Cariology Group, Dr. Basil G. Bibby.

Eligibility: Individuals who will not have reached their 40th birthday by March 16, 2011, are eligible to apply.

Criteria: The Award will be made on the basis of general excellence in research related to cariology as demonstrated by written or published reports.

Application:

Candidates may apply directly or be nominated by a member of the Cariology Group.

Supporting documents should include:

Brief curriculum vitae.
Summary of specific scientific contributions.
List of the reports or publications on which the application is based, and if possible/applicable the web-link to each of them.
Supporting statement from a colleague or member of the Cariology Group.

All documents above should be grouped into one pdf file and e-mailed to Bennett Amaechi at amaechi@uthscsa.edu.

Award:

The winner will be decided by a four-member panel and will receive a plaque and a cash award of $500. In addition, $1100 will be provided to cover registration, travel and housing expenses for the winner to attend the 2011 General Session & Exhibition of the IADR, San Diego, Calif., USA, March 16-19, 2011. The Award will be presented at the Cariology Group business meeting during the 2011 IADR General Session in San Diego.

Nomination Deadline:

Deadline for receipt of applications is: December 1, 2010.

Applications should be sent to:

Bennett T. Amaechi
Department of Community Dentistry, MC 7917
University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio, Texas 78229-3900
Tel: (210) 567-3200/3185
Fax: (210) 567-4587
E-mail: amaechi@uthscsa.edu

American Society for Clinical Pharmacology and Therapeutics Leon I. Goldberg Young Investigator Award

The Leon I. Goldberg Young Investigator Award was established in 1986 to honor a young scientist for accomplishments in the field of clinical pharmacology achieved early in his/her career.

The goal of the Leon I. Goldberg Young Investigator Award is to encourage and recognize young scientists active in the field of clinical pharmacology.

Eligibility
There are no restrictions concerning the scientific field in which nominees have earned their doctoral degrees. Nominees must be no more than 41 years of age as of March 1 of the year in which the award is presented. Although it is encouraged, a nominee need not be a member of the Society.

Prize and Presentation
The Leon I. Goldberg Young Investigator Award is presented at the ASCPT Annual Meeting. The recipient will deliver a lecture on his/her work. In addition, the recipient of the award will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration are reimbursed by the Society.

Each year, the American Society for Clinical Pharmacology and Therapeutics Scientific Awards Program seeks to recognize outstanding science in clinical pharmacology. ASCPT Awards span the continuum of clinical pharmacology and recognize every turning point in the career path from young investigator to seasoned scientist.

The deadline to submit a nomination is September 24, 2010 at 4:00pm ET.

We encourage all members to participate in this important process. If you have any questions about any of the awards or nomination procedures, please contact meetings@ascpt.org.

ASCPT
528 N Washington St
Alexandria, VA 22314

Ph: 703.836.6981
info@ascpt.org

Gary Neil Prize for Innovation in Drug Development

The Gary Neil Prize for Innovation in Drug Development was established in 2004 to honor the memory of Gary Neil, Ph.D. Dr. Neil, a former leader of worldwide Research and Development at Wyeth-Ayerst, was a pioneer in the field of drug development. Dr. Neil was instrumental in creating a highly effective drug development and strategic decision-making structure at Alza through his roles as CEO and President of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals Corporation. Dr. Neil had a significant role as a member of the boards of directors of Pharsight Corporation, Geron Corporation, Calydon and several other biotech companies.

The goal of the Gary Neil Prize for Innovation in Drug Development is to stimulate the application of innovative science to clinical drug development by recognizing outstanding individuals or teams who have been leaders in this area.

Eligibility
Individuals as well as teams who have demonstrated leadership in the application of significant, innovative science to clinical drug development. The award is open to individuals from all clinical pharmacology employment sectors.

Prize and Presentation
The Gary Neil Prize for Innovation in Drug Development will be presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $2,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.

Each year, the American Society for Clinical Pharmacology and Therapeutics Scientific Awards Program seeks to recognize outstanding science in clinical pharmacology. ASCPT Awards span the continuum of clinical pharmacology and recognize every turning point in the career path from young investigator to seasoned scientist.

The deadline to submit a nomination is September 24, 2010 at 4:00pm ET.

We encourage all members to participate in this important process. If you have any questions about any of the awards or nomination procedures, please contact meetings@ascpt.org.

ASCPT
528 N Washington St
Alexandria, VA 22314

Ph: 703.836.6981
info@ascpt.org

William B. Abrams Award in Geriatric Clinical Pharmacology

The William B. Abrams Award in Geriatric Clinical Pharmacology was established with support from the Merck Company Foundation in 1996 to honor a young investigator in geriatric clinical pharmacology for outstanding contributions to the field.

Dr. Abrams, a Past President of ASCPT, had a long and illustrious career in the pharmaceutical industry, mostly at the Merck Research Laboratories. Among his many accomplishments in geriatric clinical pharmacology, he was the founding Co-Editor of the Merck Manual of Geriatrics, created the Scientific Section on Geriatric Clinical Pharmacology of ASCPT, and developed and funded post-doctoral training programs in geriatric clinical pharmacology.

Dr. Abrams' objective in establishing this award was to encourage more young scientists to enter the field of geriatric clinical pharmacology by recognizing accomplishments in the field at the Society's Annual Meeting.

Eligibility
A nominee must be an investigator in geriatrics who is actively involved in high-quality teaching and research in geriatric clinical pharmacology.

Prize and Presentation
The William B. Abrams Award in Geriatric Clinical Pharmacology is presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society. This award is funded on behalf of Dr. Abrams through the generosity of The Merck Company Foundation.

Each year, the American Society for Clinical Pharmacology and Therapeutics Scientific Awards Program seeks to recognize outstanding science in clinical pharmacology. ASCPT Awards span the continuum of clinical pharmacology and recognize every turning point in the career path from young investigator to seasoned scientist.

The deadline to submit a nomination is September 24, 2010 at 4:00pm ET.

We encourage all members to participate in this important process. If you have any questions about any of the awards or nomination procedures, please contact meetings@ascpt.org.

ASCPT
528 N Washington St
Alexandria, VA 22314

Ph: 703.836.6981
info@ascpt.org

Rawls-Palmer Progress in Medicine Award

The Rawls-Palmer Progress in Medicine Award was established in 1978 by Dr. W. B. Rawls to further his commitment to continuing medical education and its impact on patient care.

The goal of the Rawls-Palmer Progress in Medicine Award is to incorporate the efforts of modern research in patient care and to help bridge the gap between the results of research and its application in patient care.

Eligibility
The candidate must be an investigator who is actively involved in high-quality clinical pharmacologic research and capable of delivering an engaging, comprehensive lecture on recent developments in clinical pharmacology and therapeutics.

Prize and Presentation
The Rawls-Palmer Progress in Medicine Award is presented at the ASCPT Annual Meeting. The recipient will present a lecture focusing on recent developments in clinical pharmacology. In addition, the recipient will receive a $1,000 honorarium and a plaque. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society. This award was founded through the generosity of the late Dr. and Mrs. W.B. Rawls, and honors the memory of their parents.

Each year, the American Society for Clinical Pharmacology and Therapeutics Scientific Awards Program seeks to recognize outstanding science in clinical pharmacology. ASCPT Awards span the continuum of clinical pharmacology and recognize every turning point in the career path from young investigator to seasoned scientist.

The deadline to submit a nomination is September 24, 2010 at 4:00pm ET.

We encourage all members to participate in this important process. If you have any questions about any of the awards or nomination procedures, please contact meetings@ascpt.org.

ASCPT
528 N Washington St
Alexandria, VA 22314

Ph: 703.836.6981
info@ascpt.org

Oscar B. Hunter Memorial Award in Therapeutics

The Oscar B. Hunter Memorial Award in Therapeutics was established in 1955 to honor individual scientists for outstanding contributions to clinical pharmacology and therapeutics. This award recognizes a meritorious career in drug research, excellence or contributions in direct patient care, and a distinguished teaching career.

The Oscar B. Hunter Memorial Award in Therapeutics is the Society's premier award. The goal of the award is to honor a scientist for outstanding contributions to clinical pharmacology and therapeutics over the individual's professional life.

Eligibility
A nominee must be able to provide evidence of an exemplary career in drug research, significant contributions to excellence in patient care, and a distinguished teaching career.

Prize and Presentation
The Oscar B. Hunter Memorial Award in Therapeutics is presented at the ASCPT Annual Meeting. The recipient will present a lecture summarizing the works that form the basis of the award. In addition, the recipient of the award will receive a bronze medal mounted on a plaque and a $1,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.

Each year, the American Society for Clinical Pharmacology and Therapeutics Scientific Awards Program seeks to recognize outstanding science in clinical pharmacology. ASCPT Awards span the continuum of clinical pharmacology and recognize every turning point in the career path from young investigator to seasoned scientist.

The deadline to submit a nomination is September 24, 2010 at 4:00pm ET.

We encourage all members to participate in this important process. If you have any questions about any of the awards or nomination procedures, please contact meetings@ascpt.org.

ASCPT
528 N Washington St
Alexandria, VA 22314

Ph: 703.836.6981
info@ascpt.org

Thomson Reuters/Frank Bradway Rogers Information Advancement Award

The Thomson Reuters/Frank Bradway Rogers Information Advancement Award – Recognize Technological Innovation in Health Science Information The Rogers Award, originally called the ISI Information Advancement Award, is presented annually in recognition of outstanding contributions in the use of technology to deliver health science information, in the science of information, or in the facilitation of the delivery of health science information. The award, sponsored by the Thomson Reuters, has been given since 1983. The recipient receives a cash award of $500 and will be recognized at the 2011 Annual Meeting of the Medical Library Association.

For more information on the award and past winners go to: http://www.mlanet.org/awards/honors/rogers.html. For a copy of the nomination form, eligibility information and instructions go to: http://www.mlanet.org/pdf/awards/rogers_nom_20090714.pdf. All nominations are due by November 1, 2010. Please forward this message to colleagues who might be interested. Contact Jonathan Koffel, Jury Chair (319-335-9731) or jonathan-koffel@uiowa.edu with questions.

 

Sheiner-Beal Pharmacometrics Award

Each year, the American Society for Clinical Pharmacology and Therapeutics Scientific Awards Program seeks to recognize outstanding science in clinical pharmacology. ASCPT Awards span the continuum of clinical pharmacology and recognize every turning point in the career path from young investigator to seasoned scientist.

The deadline to submit a nomination is September 24, 2010 at 4:00pm ET.

The Sheiner-Beal Pharmacometrics Award has been established as an ASCPT Award by the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF) to acknowledge the pioneering contributions of Drs. Lewis B. Sheiner and Stuart Beal to the scientific discipline of pharmacometrics.

Definition
Pharmacometrics is defined as the science that quantifies drug, disease and clinical trial information to aid efficient drug development, regulatory decisions and rational therapeutic decision making in patients. It uses models that are generally based on pharmacology, physiology, genetic constitution and/or disease for quantitative analysis of interactions between drugs and patients. The domain of pharmacometrics includes the application of techniques that address the interactions between pharmacokinetics, pharmacodynamics, pharmacogenomics and disease progression with a focus on populations and variability in the exposure-response relationship.

Goal
The goal of the Sheiner-Beal Pharmacometrics Award is to recognize outstanding achievements at the forefront of research or leadership in pharmacometrics and/or application of pharmacometric concepts and techniques to enhance research, development, regulatory evaluation and/or utilization of therapeutic products.

Eligibility
The candidate must be an investigator or leader who is actively advancing the scientific discipline of pharmacometrics and/or its impact on research, development, regulatory evaluation, or utilization of therapeutic products, and is capable of delivering an engaging and comprehensive lecture on pharmacometrics. The award is intended to recognize clinical pharmacologists, clinician scientists, computational scientists, statisticians and others in academia, industry, government agencies or consulting whose work falls within the scope of the definition of pharmacometrics.

Prize and Presentation
The Sheiner-Beal Pharmacometrics Award will be presented bi-annually at the ASCPT Annual Meeting. The recipient will present a lecture summarizing the works that form the basis of the award. In addition, the recipient will receive a $1,500 honorarium and a plaque. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.

For more information about the Sheiner-Beal Pharmacometrics Award, please contact ASCPT at (703) 836-6981 or meetings@ascpt.org.

Association for Research in Vision and Ophthalmology-AFER/Merck Innovative Ophthalmology Research Award

Thanks to a generous grant from Merck & Co., Inc., AFER is pleased to offer this series of biennial awards. The IORA encourages young researchers to undertake investigative work in critical areas of ophthalmology that may one day lead to meaningful improvements to patients' lives. It is open to researchers aged 45 years or younger who hold an MD, a PhD or an equivalent doctoral level degree. The awards are worth $70,000 per cycle.

Nominations for the 2011 ARVO-AFER/Merck Innovation Ophthalmology Research Awards have been extended to November 15, 2010.

2011 Awards and topics

The ARVO-AFER/Merck Innovation Ophthalmology Research Awards are based upon a single paper that has been published or is scheduled for publication in a peer-reviewed journal between January 1, 2009 and August 31, 2010, and is relevant to one of the two 2011 topics:

Topic 1: Stem Cell Applications to Eye Disease

* One First Place Award of $25,000
* One Second Place Award of $10,000

Topic 2: Immunology and Insight into Eye Disease

* One First Place Award of $25,000
* One Second Place Award of $10,000

In addition to the monetary awards, the recipients will be recognized at the Keynote Session of the 2011 ARVO Annual Meeting, May 1–5, 2011 in Fort Lauderdale, Florida. A luncheon will also be held in their honor with prominent members of ARVO, AFER and Merck.

Eligibility
Eligible nominees must meet the following requirements:

* 45 years of age or under at the time the paper is published
* Hold an MD or PhD degree at the time paper is published
* Must be first author on the paper
* Paper must be original and published (or be scheduled for publication) in a peer-reviewed journal between January 1, 2009 and August 31, 2010.

Although a paper may have several authors, only the first author may be nominated. The first author must be the primary investigator. If the paper has several authors, letters must be obtained from all of the other authors acknowledging the first author as the primary investigator and, therefore, the nominee for the Award.

* Individuals may nominate themselves or others may nominate them once the paper has been published.
* The Review Panel must have no-cost access to the published articles.

Nominations must specify the name of the head of the hospital department or laboratory where the research was conducted (which may not necessarily be where the candidate is currently located).

Review process

A Review Panel of internationally recognized experts convened by ARVO will review all papers based on the following criteria:

* Originality
* Scientific rigor
* Experimental design
* Soundness of conclusions

The Review Panel will submit its recommendations to the AFER Board of Governors and the ARVO Board of Trustees for final selection. The deliberations of the Review Panel and the Boards are considered confidential, and their decisions are final.

Timetable
April–November 15 2010 Nominations accepted
November 15–January 2011 Nominations reviewed and evaluated
February 15, 2011 Completion of Review Panel deliberations and submission of recommendations to the ARVO and AFER Boards
March 1, 2011 Notify awardees and announce winners
May 1, 2011 Awards presented at the ARVO Annual Meeting

All nominations must be received no later than 11:59pm EDT, November 15, 2010.

For additional information, please contact, Barbara Hollis ( +1.240.221.2940).

Association for Research in Vision And Ophthalmology (ARVO)
1801 Rockville Pike, Suite 400
Rockville, MD 20852-5622

Phone: +1.240.221.2950
Fax: +1.240.221.0370